Public Tender Announcement for the Preparation Service of Key Intermediate RDN for Anti-tumor Drugs at Shandong University

This public tender, announced by Shandong University in China, is for the 'preparation services for the key intermediate of anti-tumor drug RDN'. The contracting authority is Shandong University, with Shandong Yingda Tendering Co., Ltd. acting as the tendering agency.

This procurement falls under research and development services, specifically seeking specialized chemical synthesis expertise. The university requires a service provider capable of producing a specific key intermediate compound essential for the development of an anti-tumor drug. Typical requirements for such a tender include a high level of technical proficiency in organic chemistry and pharmaceutical synthesis, adherence to strict quality control standards (e.g., Good Laboratory Practice - GLP), and the ability to scale up production from laboratory to pilot or intermediate quantities. Bidders are expected to demonstrate relevant experience in synthesizing complex organic molecules, particularly for pharmaceutical applications.

Proposals should detail the proposed synthesis route, analytical methods for quality assurance, expected yield and purity of the intermediate, production timeline, confidentiality measures, and pricing. Collaboration with academic research institutions often requires flexibility and robust communication protocols.